Making Better Decisions: Policy Modeling for AIDS and Drug Abuse

做出更好的决策:艾滋病和药物滥用的政策建模

基本信息

  • 批准号:
    7468457
  • 负责人:
  • 金额:
    $ 63.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-25 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The severity of the HIV epidemic and limits on prevention and treatment resources have forced planners and providers to make difficult choices about which interventions to implement to prevent and treat HIV and substance abuse. The goal of our project is to evaluate existing and potential HIV and substance abuse interventions to provide critical information on effectiveness, public-health impact, and efficiency. This project aims to promote reasoned planning and policy making in the realm of HIV and substance abuse prevention and treatment via the development of mathematical and economic models. To achieve this goal, we have the following specific aims: 1. To estimate production functions that characterize the relationship between program expenditures and health outcomes, such as reductions in risky behaviors for prevention programs and delivery of services for treatment programs 2. To develop model-based methods of translating the behavioral impact of HIV-related interventions into epidemiologically meaningful outcome measures, such as years of life saved. 3. To determine how best to estimate health outcomes, economic outcomes, and cost effectiveness of HIV and substance abuse interventions. 4. To assess the effectiveness and cost-effectiveness of specific interventions aimed at preventing and treating HIV and substance abuse. 5. To inform the allocation of societal resources by examining the effectiveness and cost effectiveness of portfolios of prevention and treatment interventions. This work includes analyzing national and international HIV prevention and treatment strategies, and assessing how to balance HIV prevention and treatment interventions to achieve the greatest health benefit. 6. To examine the relationship between policy modeling and public health decision making in the areas of HIV and substance abuse - in particular, to explore how to make analyses most useful to policy makers. The proposed research will advance the state of the art in HIV planning and policy modeling, critically evaluate promising interventions, and help provide the scientific foundation for allocation of scarce resources to portfolios of HIV and substance abuse prevention and treatment interventions.
描述(由申请人提供):艾滋病毒流行的严重性和对预防和治疗资源的限制迫使规划者和提供者作出困难的选择,实施哪些干预措施,以预防和治疗艾滋病毒和药物滥用。我们项目的目标是评估现有和潜在的艾滋病毒和药物滥用干预措施,以提供有关有效性、公共卫生影响和效率的关键信息。该项目旨在通过开发数学和经济模型,促进艾滋病毒和药物滥用预防和治疗领域的合理规划和决策。为实现这一目标,我们有以下具体目标:1.为了估计生产函数的特征之间的关系的程序支出和健康的结果,如减少危险行为的预防计划和提供服务的治疗方案2。开发基于模型的方法,将艾滋病毒相关干预措施的行为影响转化为流行病学上有意义的结果指标,如挽救的生命年数。3.确定如何最好地估计艾滋病毒和药物滥用干预措施的健康结果、经济结果和成本效益。4.评估旨在预防和治疗艾滋病毒和药物滥用的具体干预措施的有效性和成本效益。5.通过审查预防和治疗干预措施组合的有效性和成本效益,为社会资源的分配提供信息。这项工作包括分析国家和国际艾滋病毒预防和治疗战略,并评估如何平衡艾滋病毒预防和治疗干预措施,以实现最大的健康效益。6.研究艾滋病毒和药物滥用领域的政策建模与公共卫生决策之间的关系,特别是探讨如何使分析对决策者最有用。拟议的研究将推进艾滋病毒规划和政策建模的最新水平,批判性地评估有希望的干预措施,并帮助为将稀缺资源分配给艾滋病毒和药物滥用预防和治疗干预措施提供科学基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS K OWENS其他文献

DOUGLAS K OWENS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS K OWENS', 18)}}的其他基金

Cost Effectiveness of Interventions to Reduce Morbidity from Opioid Dependency
降低阿片类药物依赖发病率的干预措施的成本效益
  • 批准号:
    10862526
  • 财政年份:
    2018
  • 资助金额:
    $ 63.69万
  • 项目类别:
Cost Effectiveness of Interventions to Reduce Morbidity from Opioid Dependency
降低阿片类药物依赖发病率的干预措施的成本效益
  • 批准号:
    9688396
  • 财政年份:
    2018
  • 资助金额:
    $ 63.69万
  • 项目类别:
Cost Effectiveness of Interventions to Reduce Morbidity from Opioid Dependency
降低阿片类药物依赖发病率的干预措施的成本效益
  • 批准号:
    10186543
  • 财政年份:
    2018
  • 资助金额:
    $ 63.69万
  • 项目类别:
Cost Effectiveness of Interventions to Reduce Morbidity from Opioid Dependency
降低阿片类药物依赖发病率的干预措施的成本效益
  • 批准号:
    10308559
  • 财政年份:
    2018
  • 资助金额:
    $ 63.69万
  • 项目类别:
Cost-effective Uses of New Hepatitis C Treatments and their VA Budgetary Impact
新的丙型肝炎治疗方法的成本效益及其对 VA 预算的影响
  • 批准号:
    8473515
  • 财政年份:
    2013
  • 资助金额:
    $ 63.69万
  • 项目类别:
Management of HIV as a Chronic Disease
将艾滋病毒作为一种慢性疾病进行管理
  • 批准号:
    8273482
  • 财政年份:
    2012
  • 资助金额:
    $ 63.69万
  • 项目类别:
Comparative effectiveness of ART for HIV in patients with comorbidities
ART 对患有合并症的患者的 HIV 治疗效果比较
  • 批准号:
    7936273
  • 财政年份:
    2009
  • 资助金额:
    $ 63.69万
  • 项目类别:
Comparative effectiveness of ART for HIV in patients with comorbidities
ART 对患有合并症的患者的 HIV 治疗效果比较
  • 批准号:
    7839702
  • 财政年份:
    2009
  • 资助金额:
    $ 63.69万
  • 项目类别:
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
做出更好的决策:艾滋病和药物滥用的政策建模
  • 批准号:
    8094334
  • 财政年份:
    2002
  • 资助金额:
    $ 63.69万
  • 项目类别:
Making Better Decisions: Policy Modeling-AIDS/Drug Abuse
做出更好的决策:政策建模 - 艾滋病/药物滥用
  • 批准号:
    7084434
  • 财政年份:
    2002
  • 资助金额:
    $ 63.69万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 63.69万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 63.69万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 63.69万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 63.69万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 63.69万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 63.69万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 63.69万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 63.69万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 63.69万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 63.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了